{
    "1711846395399881049": {
        "author_id": "194037150",
        "created_at": "2023-10-10T20:49:19.000Z",
        "edit_history_tweet_ids": [
            "1711846395399881049"
        ],
        "entities": {
            "annotations": [
                {
                    "end": 18,
                    "normalized_text": "Novo Nordisk",
                    "probability": 0.5873,
                    "start": 7,
                    "type": "Organization"
                }
            ],
            "hashtags": [
                {
                    "end": 6,
                    "start": 0,
                    "tag": "PRESS"
                }
            ]
        },
        "id": "1711846395399881049",
        "lang": "en",
        "public_metrics": {
            "bookmark_count": 4,
            "impression_count": 20993,
            "like_count": 89,
            "quote_count": 7,
            "reply_count": 5,
            "retweet_count": 27
        },
        "text": "#PRESS Novo Nordisk will stop the kidney outcomes trial, FLOW, based on interim analysis"
    }
}